BiomX (PHGE) Common Equity (2018 - 2026)

BiomX has disclosed Common Equity across 9 years of filings, most recently posting $17.6 million for Q2 2026.

• In Q2 2026, Common Equity fell 8.02% year-over-year to $17.6 million; the TTM figure through Jun 2026 stood at $17.6 million (down 8.02% YoY), while the FY2025 annual figure was -$1.3 million, down 105.39% from the prior year.
• Common Equity came in at $17.6 million for Q2 2026 at BiomX, up from -$881000.0 in the prior quarter.
• In the past five years, Common Equity ranged from a high of $40.0 million in Q1 2022 to a low of -$1.3 million in Q4 2025.
• Average Common Equity over 5 years is $18.8 million, with a median of $18.4 million recorded in 2025.
• Year-over-year, Common Equity soared 683.77% in 2024 and tumbled 105.39% in 2025.
• Over 5 years, Common Equity stood at $21.0 million in 2022, then tumbled by 85.36% to $3.1 million in 2023, then soared by 683.77% to $24.1 million in 2024, then plunged by 105.39% to -$1.3 million in 2025, then surged by 1453.53% to $17.6 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $17.6 million in Q2 2026, -$881000.0 in Q1 2026, and -$1.3 million in Q4 2025.